US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Zomedica Corp.

0.0770

-0.0054-6.55%

Volume:2.34M

Turnover:186.44K

Market Cap:75.46M

PE:-3.34

High:0.0825

Open:0.0825

Low:0.0751

Close:0.0824

52wk High:0.1580

52wk Low:0.0350

Shares:979.95M

Float Shares:943.24M

Volume Ratio:1.55

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0230

ROE:-18.56%

ROA:-11.67%

PB:0.68

PE(LYR):- -

Loading ...

Overview Company News Filings

Zomedica shareholders reject executive pay proposal at annual meeting

Zomedica to host “Fourth Friday at Four” investor webinar on Five Pillars strategy framework

Zomedica SVP Sales Kevin Klass reports acquisition of 104,000 common shares worth $10,712

Zomedica director Johnny D. Powers reports buying 200,000 common shares for $20,600

Zomedica SVP Sales Kevin Klass reports buying 216,899 shares for $22,786.69

Seagate, Schwab, Zomedica, Constellation, Lumentum Shake Markets

Zomedica director Johnny D. Powers reports $31,700 common share purchase

Zomedica Director Johnny D. Powers acquires 500,000 shares for $56,201

HPE, Charles Schwab, Zomedica, Illumina, Circle Insider Shake-Up

Zomedica CEO Larry Heaton buys 250,000 shares for $27,500

Zomedica Q1 FY26 net loss narrows 93% to $4.53 million; revenue rises 35% to $8.8 million

Zomedica to host “Fourth Friday at Four” investor webinar on manufacturing operations

Zomedica announces annual shareholder meeting notice

Zomedica Collaborates With Boehringer Ingelheim to Expand Equine PPID Testing on TRUFORMA

Zomedica FY 2025 net loss widened 74% to USD 81.86 million on revenue up 17% to USD 32.03 million

Zomedica to host investor webinar reviewing 2025 results and equine market opportunity

Zomedica Showcases R&D Strategy in Investor Webinar

Zomedica Signs Contract Manufacturing Agreement with Rahm Sensor Development

Zomedica Unveils Digital Innovation Strategy in Investor Webinar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ZOMDF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZOMDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZOMDF\",,,,,undefined,":{"symbol":"ZOMDF","market":"US","secType":"STK","nameCN":"Zomedica Corp.","latestPrice":0.077,"timestamp":1781812800000,"preClose":0.0824,"halted":0,"volume":2336074,"delay":15,"changeRate":-0.0655339805825243,"floatShares":943240860,"shares":979949668,"eps":-0.023045,"marketStatus":"Market Closed","change":-0.0054,"latestTime":"06-18 16:00:00 EDT Delay","open":0.0825,"high":0.0825,"low":0.0751,"amount":186435.87292099997,"amplitude":0.089806,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.023045,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"listingDate":1741150800000,"exchange":"OTCQB","adjPreClose":0.0824,"volumeRatio":1.5536286856579273},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZOMDF\",,,,,undefined,":{"symbol":"ZOMDF","floatShares":943240860,"roa":"-11.67%","roe":"-18.56%","lyrEps":0,"volumeRatio":1.5536286856579273,"shares":979949668,"dividePrice":0,"high":0.0825,"amplitude":0.089806,"preClose":0.0824,"low":0.0751,"week52Low":0.035,"pbRate":"0.68","psRate":"2.20","week52High":0.158,"institutionHeld":0,"latestPrice":0.077,"eps":-0.023045,"divideRate":0,"volume":2336074,"delay":15,"ttmEps":-0.023045,"open":0.0825,"prevYearClose":0.10175,"prevWeekClose":0.0995,"prevMonthClose":0.1026,"prevQuarterClose":0.1194,"fiveDayClose":0.0983,"twentyDayClose":0.107,"sixtyDayClose":0.125},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZOMDF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-06","symbol":"ZOMDF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-15","symbol":"ZOMDF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZOMDF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZOMDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZOMDF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642757231","title":"Zomedica shareholders reject executive pay proposal at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642757231","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642757231?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:17","pubTimestamp":1781209021,"startTime":"0","endTime":"0","summary":"Zomedica held its annual shareholder meeting on June 10, 2026.Investors adopted a bylaw amendment changing quorum requirements for any adjourned shareholder meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL3G2PLQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642544755","title":"Zomedica to host “Fourth Friday at Four” investor webinar on Five Pillars strategy framework","url":"https://stock-news.laohu8.com/highlight/detail?id=2642544755","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642544755?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:02","pubTimestamp":1781085728,"startTime":"0","endTime":"0","summary":"Zomedica will host its “Fourth Friday at Four” investor webinar on June 26, 2026, at 4:00 p.m. ET.Session will outline the company’s “Five Pillars” strategy, linking product adoption to recurring revenue and shareholder returns.Management plans to review portfolio execution across diagnostics, therapy, imaging, monitoring, home care, with emphasis on utilization and retention economics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL5qwWkv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511528","title":"Zomedica SVP Sales Kevin Klass reports acquisition of 104,000 common shares worth $10,712","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511528","media":"Reuters","labels":["shareholding","insiderTrades","merge","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511528?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:42","pubTimestamp":1779795747,"startTime":"0","endTime":"0","summary":"Zomedica: Senior Vice President of Sales Kevin Klass reported a 104,000-share purchase at $0.1 per share, held indirectly through a spouse.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL7gQ4lW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zomedica SVP Sales Kevin Klass reports acquisition of 104,000 common shares worth $10,712","news_tag":"shareholding,insiderTrades,merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637354570","title":"Zomedica director Johnny D. Powers reports buying 200,000 common shares for $20,600","url":"https://stock-news.laohu8.com/highlight/detail?id=2637354570","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637354570?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:17","pubTimestamp":1779394628,"startTime":"0","endTime":"0","summary":"Zomedica director Johnny D. Powers bought 200,000 shares of common stock at USD 0.10 each.His direct holdings rose to 4,425,000 shares following the purchases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL3689zh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637935451","title":"Zomedica SVP Sales Kevin Klass reports buying 216,899 shares for $22,786.69","url":"https://stock-news.laohu8.com/highlight/detail?id=2637935451","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637935451?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:15","pubTimestamp":1779394547,"startTime":"0","endTime":"0","summary":"Zomedica: Senior Vice President, Sales Kevin Klass increased his stake through open-market purchases.Added 216,899 common shares at prices ranging from USD 0.105 to USD 0.107 per share.Beneficial ownership rose to 6,001,000 common shares held directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL2w24bd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zomedica SVP Sales Kevin Klass reports buying 216,899 shares for $22,786.69","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635706563","title":"Seagate, Schwab, Zomedica, Constellation, Lumentum Shake Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2635706563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635706563?lang=en_us&edition=fundamental","pubTime":"2026-05-16 21:01","pubTimestamp":1778936486,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($STX)), (($SCHW)), (($ZOMDF)), (($STZ)) and (($LITE)). Here is a breakdown of their recent trades and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/seagate-schwab-zomedica-constellation-lumentum-shake-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/seagate-schwab-zomedica-constellation-lumentum-shake-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0205194284.USD","LU1861220033.SGD","LU1861215975.USD","STX","LITX","LU0012050646.USD","LU0289739343.SGD","SCHW","LU2290526834.HKD","LU2360107168.USD","BK4585","LU0511384066.AUD","LU0240878834.USD","LU0240877869.USD","STZ.B","LU0205193047.USD","LU0106261612.USD","BK4020","LU0348723411.USD","ZOMDF","LU0289961442.SGD","BK4588","LITE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635725377","title":"Zomedica director Johnny D. Powers reports $31,700 common share purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2635725377","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635725377?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:18","pubTimestamp":1778789899,"startTime":"0","endTime":"0","summary":"Zomedica director Johnny D. Powers reported open-market purchases totaling 300,000 common shares.Purchases were executed at prices of USD 0.105 to USD 0.106 per share.Powers reported direct ownership of 4,225,000 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL9SP3mn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zomedica director Johnny D. Powers reports $31,700 common share purchase","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634237458","title":"Zomedica Director Johnny D. Powers acquires 500,000 shares for $56,201","url":"https://stock-news.laohu8.com/highlight/detail?id=2634237458","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634237458?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:18","pubTimestamp":1778530712,"startTime":"0","endTime":"0","summary":"Zomedica director Johnny D. Powers reported open-market purchases totaling 500,000 common shares.Purchases were priced at USD 0.11 per share.Powers’ direct holding rose to 3,925,000 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL4T0sMY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zomedica Director Johnny D. Powers acquires 500,000 shares for $56,201","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634415903","title":"HPE, Charles Schwab, Zomedica, Illumina, Circle Insider Shake-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2634415903","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634415903?lang=en_us&edition=fundamental","pubTime":"2026-05-09 21:01","pubTimestamp":1778331706,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($HPE)), (($SCHW)), (($ZOMDF)), (($ILMN)) and (($CRCL)). Here is a breakdown of their recent trades and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/hpe-charles-schwab-zomedica-illumina-circle-insider-shake-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/hpe-charles-schwab-zomedica-illumina-circle-insider-shake-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861217088.USD","BK4534","LU1861558580.USD","LU0648001328.SGD","LU2264538146.SGD","BK4581","LU0011850046.USD","LU0321505439.SGD","LU0310800379.SGD","LU1074936037.SGD","LU1363072403.SGD","LU0971096721.USD","LU1153585028.USD","LU0708994859.HKD","LU0128525929.USD","ILMN","LU1280957306.USD","LU1791807156.HKD","SG9999014021.USD","CCUP","SCHW","LU1069347547.HKD","IE000M9KFDE8.USD","LU1201861249.SGD","BK4588","CRCD","ICRC","BK4121","LU0251142724.SGD","LU1868836591.USD","LU2360107671.USD","LU1868836914.USD","IE00B7SZLL34.SGD","LU0061475181.USD","BK4585","LU0130517989.USD","LU0742534661.SGD","LU0266013472.USD","LU1035773651.USD","CRCL","CRCA","LU1267930573.SGD","BK4535","LU0980610538.SGD","IE0002270589.USD","LU0348723411.USD","LU0106831901.USD","LU0345774391.USD","LU0985481810.HKD","ZOMDF","LU0345774631.USD","LU0477156953.USD","SG9999014005.SGD","LU1861220207.SGD","LU1868836757.USD","LU0640476718.USD","LU1861559042.SGD","BK4023","LU0225771236.USD","CRCO","LU0096364046.USD","LU0321505868.SGD","BK4504","IE00B19Z3581.USD","SG9999014013.SGD","LU1668664300.SGD","LU0225284248.USD","LU0130102774.USD","HPE","BK4515","LU0251131958.USD","SG9999014039.USD","BK4548","LU0306806265.USD","LU0048573561.USD","LU1988902786.USD","LU1868837300.USD","LU1868837136.USD","LU0306807586.USD","IE00B19Z3B42.SGD","LU0006061336.USD","BK4127","LU1064131342.USD","SG9999001077.SGD","CRCG","BK4170","BK4589","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634208464","title":"Zomedica CEO Larry Heaton buys 250,000 shares for $27,500","url":"https://stock-news.laohu8.com/highlight/detail?id=2634208464","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634208464?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:17","pubTimestamp":1778271420,"startTime":"0","endTime":"0","summary":"Zomedica CEO Larry C. Heaton II reported a purchase of 250,000 common shares at USD 0.11 each.Directly held stake rose to 1,250,000 shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDLb6WJjj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zomedica CEO Larry Heaton buys 250,000 shares for $27,500","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633526791","title":"Zomedica Q1 FY26 net loss narrows 93% to $4.53 million; revenue rises 35% to $8.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633526791","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633526791?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:28","pubTimestamp":1778099301,"startTime":"0","endTime":"0","summary":"Zomedica posted a net loss of USD 4.53 million for quarter ended March 31, 2026, narrowing 93%.Revenue rose 35% to USD 8.8 million, while gross margin slipped 6 percentage points to 62% on a change in product mix.Total operating expenses fell, led by general and administrative expense down 14% to USD 5.41 million, research and development down 38% to USD 1.15 million, selling and marketing down 24% to USD 3.82 million.Cash and cash equivalents ended period at USD 9.37 million, up 6%, while cash used in operating activities improved 21% to USD 5.26 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDLb5QNHx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628244956","title":"Zomedica to host “Fourth Friday at Four” investor webinar on manufacturing operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2628244956","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628244956?lang=en_us&edition=fundamental","pubTime":"2026-04-17 05:33","pubTimestamp":1776375201,"startTime":"0","endTime":"0","summary":"Zomedica scheduled “Fourth Friday at Four” investor webinar for April 24, 2026 at 4:00 p.m. ET.Session will focus on manufacturing scale-up and quality operations across Roswell, Georgia and Plymouth, Minnesota facilities.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL9nDgWs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627421668","title":"Zomedica announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2627421668","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627421668?lang=en_us&edition=fundamental","pubTime":"2026-04-15 04:09","pubTimestamp":1776197388,"startTime":"0","endTime":"0","summary":"Zomedica scheduled annual shareholder meeting for June 10, 2026, to be held virtually.Shareholders will vote to elect eight directors to serve until next annual meeting.Ballot includes ratification of Grant Thornton as independent registered public accounting firm for 2026.Advisory vote will be held on compensation for named executive officers.Meeting will also consider amendment to company by-laws to limit adjourned shareholder meetings by changing quorum requirements for an adjourned meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDLZ3WJc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620231416","title":"Zomedica Collaborates With Boehringer Ingelheim to Expand Equine PPID Testing on TRUFORMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2620231416","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620231416?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:00","pubTimestamp":1773828026,"startTime":"0","endTime":"0","summary":"Zomedica entered a collaboration with Boehringer Ingelheim to expand equine endocrine diagnostic testing for pituitary pars intermedia dysfunction  using the TRUFORMA platform. The arrangement integrates TRUFORMA into Boehringer Ingelheim’s idPPID awareness and testing program, enabling point-of-care testing using Zomedica’s equine endogenous ACTH and equine insulin assays. Zomedica will promote the idPPID program to veterinarians in its TRUFORMA and PulseVet customer networks, while Boehringer Ingelheim will reimburse participating veterinarians for TRUFORMA-based testing and laboratory testing at Cornell University. The program includes no-cost placement of TRUFORMA analyzers in equine practices and reimbursement for diagnostic cartridge kits, with participating veterinarians able to reorder additional assays including Cortisol and Progesterone.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL27FXtQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620499114","title":"Zomedica FY 2025 net loss widened 74% to USD 81.86 million on revenue up 17% to USD 32.03 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620499114","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620499114?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:10","pubTimestamp":1773691803,"startTime":"0","endTime":"0","summary":"Zomedica published its annual report on Form 10-K for FY 2025. Revenue rose 17% to USD 32.03 million, driven mainly by contract manufacturing and engineering revenue, growth in PulseVet consumables, growth in TRUFORMA products including new assay launches, and initial sales of VETIGEL. Net loss widened 74% to USD 81.86 million, primarily due to impairment expense of USD 55.83 million tied to a sharp decline in market capitalization following the company’s delisting from NYSE American. Cash used in operating activities fell 25% to USD 17.65 million, reflecting lower operating expenses excluding non-cash charges. Cash and cash equivalents ended the year at USD 9.02 million, and management said existing cash is sufficient to fund expected short-term needs and long-term operational requirements.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL4zvQNH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618390819","title":"Zomedica to host investor webinar reviewing 2025 results and equine market opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2618390819","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618390819?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:30","pubTimestamp":1773138631,"startTime":"0","endTime":"0","summary":"Zomedica to host investor webinar reviewing 2025 results and equine market opportunity               Zomedica will host a “Fourth Friday at Four” investor webinar on March 27, 2026 at 4:00 p.m. ET to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDLcPWdm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609757379","title":"Zomedica Showcases R&D Strategy in Investor Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2609757379","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609757379?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:30","pubTimestamp":1770291041,"startTime":"0","endTime":"0","summary":"Zomedica Corp. will host its next \"Fourth Friday at Four\" investor webinar on Friday, February 27, 2026, at 4:00 p.m. Eastern Time. The event, titled \"Inside Innovation: Advancing Animal Health Through Research & Development,\" will focus on the company's R&D strategy, its expanding product portfolio, and long-term growth objectives. The session will include prepared remarks and a Q&A, providing insights into Zomedica's innovation pipeline and a behind-the-scenes look at its Plymouth facility. Registration for the event is available online.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire  on February 05, 2026, and is solely responsible for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL4c72Vq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605981014","title":"Zomedica Signs Contract Manufacturing Agreement with Rahm Sensor Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2605981014","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605981014?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:30","pubTimestamp":1769081431,"startTime":"0","endTime":"0","summary":"Zomedica Corp. announced that it has entered into a contract manufacturing and service agreement with Rahm Sensor Development. Under the agreement, Zomedica will manufacture Rahm's Cell-Guardian, a personnel monitoring device designed for high-risk environments, and provide engineering services and customer support. The partnership is expected to generate incremental, contract-based revenue for Zomedica and expand its revenue streams beyond animal health by utilizing existing manufacturing and engineering capabilities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire  on January 22, 2026, and is solely responsible for the information contai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL3nRl95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOMDF","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603769016","title":"Zomedica Unveils Digital Innovation Strategy in Investor Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2603769016","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603769016?lang=en_us&edition=fundamental","pubTime":"2026-01-14 19:30","pubTimestamp":1768390229,"startTime":"0","endTime":"0","summary":"Zomedica Corp. will host its next \"Fourth Friday at Four\" investor webinar on Friday, January 23, 2026, at 4:00 p.m. Eastern Time. The session, titled \"Digital Advantage: Powering Scalable Growth Through Innovation,\" will focus on the company's expanding digital capabilities and long-term innovation strategy in veterinary diagnostics and therapeutics. The event will feature prepared remarks followed by a question and answer session. Interested participants can register online.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire  on January 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL9ql6Ch:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZOMDF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}